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Complete alanine scanning of the 
Escherichia coli RbsB ribose binding 
protein reveals residues important 
for chemoreceptor signaling and 
periplasmic abundance
Artur Reimer, Vitali Maffenbeier, Manupriyam Dubey, Vladimir Sentchilo, Diogo Tavares, 
Manuel Hernandez Gil, Siham Beggah & Jan Roelof van der Meer  
The Escherichia coli RbsB ribose binding protein has been used as a scaffold for predicting new ligand 
binding functions through in silico modeling, yet with limited success and reproducibility. In order to 
possibly improve the success of predictive modeling on RbsB, we study here the influence of individual 
residues on RbsB-mediated signaling in a near complete library of alanine-substituted RbsB mutants. 
Among a total of 232 tested mutants, we found 10 which no longer activated GFPmut2 reporter 
expression in E. coli from a ribose-RbsB hybrid receptor signaling chain, and 13 with significantly lower 
GFPmut2 induction than wild-type. Quantitative mass spectrometry abundance measurements of 
25 mutants and wild-type RbsB in periplasmic space showed four categories of effects. Some (such as 
D89A) seem correctly produced and translocated but fail to be induced with ribose. Others (such as 
N190A) show lower induction probably as a result of less efficient production, folding and translocation. 
The third (such as N41A or K29A) have defects in both induction and abundance. The fourth category 
consists of semi-constitutive mutants with increased periplasmic abundance but maintenance of 
ribose induction. Our data show how RbsB modeling should include ligand-binding as well as folding, 
translocation and receptor binding.
Bacteria have been increasingly used as chassis for the construction of biosensors (“bioreporters” or “bactosen-
sors”), which can be applied for easy measurements of toxic compounds in environmental samples1–3, of clinically 
relevant biomolecules4 or of metabolites in industrial processes5. In order to function in a biosensor the reporter 
cell is equipped with a genetic circuit encoding a sensory protein, which directly or indirectly alters transcription 
of a so-called reporter gene from a dedicated orthogonal promoter in presence of the molecular target6–9.
One of the critical shortcomings of current bioreporters is the choice of sensory protein to operate the cir-
cuitry. Most bioreporters exploit naturally existing sensory proteins or transcription factors with their cognate 
target recognition properties10, but for many pollutants or compounds of interest no natural sensory proteins 
are known. Random mutagenesis of existing transcription factors followed by rigorous selection strategies have 
produced some mutants with interesting properties11–13, but this is a cumbersome approach that has to be opti-
mized for each new protein scaffold. As an alternative for a potentially more universal mutagenesis and selection 
platform periplasmic binding proteins (PBPs) have been proposed. PBPs form a versatile superfamily of proteins, 
which due to their wide range of natural ligands and their abundance throughout different classes of microorgan-
isms exhibit a good potential for protein engineering14. A seminal publication in 2003 by Looger et al. suggested 
the successful design of bioreporters based on PBPs with the help of computational protein prediction for specific 
detection of non-natural targets down to the nanomolar range15. Of special interest in bespoke publication was 
the design of a mutant of the RbsB ribose binding protein of Escherichia coli supposedly able to bind trinitrotol-
uene (TNT) with an affinity constant of 2 nM, and which, when expressed in E. coli, would elicit formation of 
beta-galactosidase from a hybrid signaling chain at concentrations as low as 0.1 nM TNT15. Despite the beauty of 
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the concept, recent publications have been unable to reproduce the initial findings16, 17, and it has been suggested 
that the designed mutants resulted in unstable proteins18. In addition, it is likely that the initial computations con-
centrated solely on calculating new PBP binding site specificities on the basis of existing crystal structures with 
or without bound ligand, but neglecting the other characteristics of a functional PBP. This may include processes 
such as: folding and translocation into the periplasm, dynamic ligand-binding (cleft opening and closing), and 
productive interactions of ligand-bound PBP to its membrane channel or receptor19–23. Possibly, computational 
design of binding specificities of dynamic proteins such as PBPs can be improved with better scoring functions 
that embed empirical data on each step of its functional cascade. As a start to better functionally characterize the 
importance of amino acid residues of RbsB in the complete ribose-induced signaling chain, we carried out an 
alanine scan of the near complete protein. Results from a limited alanine scan of RbsB have been published pre-
viously24. To proceed, a total of 235 RbsB mutants were produced by DNA synthesis in which the original residue 
was replaced by Ala. These mutants were individually expressed in an E. coli chassis with the Trz1 hybrid signaling 
pathway between the periplasmic part of the Trg chemoreceptor and the cytoplasmic part of EnvZ, enabling pro-
duction of the GFPmut2 fluorescent protein16, 25 in response to ribose addition (Fig. 1). GFPmut2 expression was 
analyzed by flow cytometry in cells exposed or not to ribose. Additionally, RbsB levels in the periplasmic space of 
E. coli were quantified by nano liquid chromatography followed by direct peptide mass identification (LC-MS) in 
a selection of 25 mutants with the strongest defects plus the wild-type. Our results highlight a variety of critical 
amino acid residues for ribose-induced RbsB signaling also at seemingly inconspicuous positions, which help to 
understand previous irreproducible design results.
Results
Production of an Ala-substitution library of RbsB. A near-complete Ala-substitution library of the 
E. coli RbsB protein was produced from a combination of pooled mutant DNA synthesis and individual mutant 
recovery or construction. Despite multiple repeated attempts, three replacements could not be obtained (i.e., 
135T, 136S and 145F). 37 positions (14%) of RbsB wild-type contain an Ala-residue and were not further changed 
in this work. All mutant rbsB genes were transferred to the generic vector pSTVPAAmcs for expression from 
the constitutive PAA-promoter16, and verified by sequencing again after final cloning. Noteworthy, several Ala-
replacements in RbsB led to appreciable slower growth of the E. coli expression strain, apparent as smaller colo-
nies on plates and lower counts in flow cytometry analysis (Fig. S1).
Effect of Ala-substitution on inducibility with ribose. The final 232 mutants were analyzed in trip-
licate assays by flow cytometry for GFPMut2 fluorescence as a result of induction by ribose from the hybrid 
Trz1-OmpR-ompCp-gfpmut2 signaling chain (Fig. 1), in comparison to E. coli expressing wild-type RbsB (strain 
4175) as well as E. coli without rbsB (strain 4497) (Dataset 1). Inducibility with 1 mM ribose was measured on 
cultures grown and exposed in 96-well plates on different occasions; therefore, every plate contained a separate 
triplicate wild-type positive and a negative control. In general terms, we observed both partial and complete loss 
of inducibility by ribose, appearance of semiconstitutives (with higher values of GFPMut2 fluorescence than 
wild-type in cells not exposed to ribose), as well as similar inducibility as wild-type RbsB (Fig. 2 and Dataset 1). 
Ten percent of Ala-substitutions led to a loss of ribose induction, which we defined from a fluorescence less 
than the average minus two standard deviations (SD), calculated from the data variation among all mutants and 
Figure 1. Schematic outline of the ribose-binding protein-based Gfpmut2 reporter signaling chain in E. coli. 
Ribose-binding protein (RbsB) captures its ligand ribose, leading to a conformational change. Ribose-RbsB 
binds the Trz1 hybrid transmembrane receptor, which causes a phosphorylation cascade leading to OmpR-P 
binding the ompC-promoter and consecutive gfpmut2 expression.
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wild-type (Fig. 2B and Dataset 1). Among those, half were not inducible at all, or even showed lower fluorescence 
in presence than in absence of ribose. Approximately, seven percent led to a statistically significant increased 
GFPMut2 fluorescence (i.e., higher than the average plus two SD) in absence of ribose compared to wild-type 
RbsB (Fig. 2A and Dataset 1). Ribose induction profiles allowed to group the Ala-replacement mutants of RbsB 
loosely into three broad groups shown in Table 1, based on the criteria described above (e.g., no or weak induc-
tion, semi-constitutive).
RbsB mutant periplasmic space abundance. Since some of the differences in ribose induction com-
pared to wild-type RbsB may be due to differences in RbsB-mutant stability, folding and/or translocation to the 
periplasmic space, we analyzed periplasmic protein abundance for a selection of 25 mutants with the strongest 
defects from the groups in Table 1, and of wild-type, grown under standard conditions as for ribose induction. 
Analysis of SDS-PAGE separated periplasmic protein fraction in the range of 28–40 kDa, trypsin-digested and 
quantified by nano LC-MS, revealed a total of 424 distinct proteins (Fig. S2). RbsB (mutant) peptides were iden-
tified and quantified from unique fragments (exclusive spectrum count), normalized by total spectrum count 
per sample and further by D-galactose-binding periplasmic protein (MglB) counts as internal standard (Table 2). 
Samples with a significantly lower abundance of RbsB mutant peptides than expected from variation of the MglB 
internal standard (F-test; p < 0.05) were considered carrying a mutation affecting folding, translocation and/or 
stability of the mutant RbsB in(to) the E. coli periplasm (Table 3). Assuming proportional decrease of GFPmut2 
expression and the normalized RbsB periplasmic abundance (Table 3), we conclude that Ala-substitutions at D89, 
V106, I111, R141, G144, V186, G196, D215, P262, and D264 primarily have signaling defects, since their abun-
dance is similar (or even slightly higher) as wild-type, but GFPmut2 fluorescence upon induction with ribose is 
lower (Table 3). In contrast, Ala-substitutions at I63, I86, N190 and I233 primarily seem to affect protein synthe-
sis, folding, stability and/or translocation, since their fluorescence decreases (except for I63, a semi-constitutive) 
as much as their abundance in comparison to wild-type RbsB (Table 3). Ala-substitutions in L6, T10, K29, G31, 
L34, L88, N41 and L195 seem to affect both processes, since the loss in abundance is not sufficient to explain the 
decrease in normalized fluorescence through the signaling chain (again assuming proportionality between the 
two, Table 3). Of note that MglB abundance in mutants L6A, V106A and V186A itself was lower than expected 
from the variance across all samples (Table 3). Therefore, these RbsB mutants may fold to such a state that they 
block general protein translocation channels for other periplasmic binding proteins. Mutants P237A and I111A 
showed higher than expected abundance but lower normalized fluorescence and, therefore, are also impaired 
in signaling. Finally, mutants I132A and N105A showed a higher level of periplasmic abundance than expected 
from wild-type RbsB, but only N105A expressed constitutively higher GFPmut2 fluorescence in absence of ribose 
(Table 1).
Figure 2. GFPMut2 average fluorescence values from the E. coli Trz1-OmpR, ompCp-gfpmut2 signaling chain 
for each RbsB mutant, sorted by position. (A) Values for uninduced conditions (i.e., absence of ribose). (B) 
Values after 2 h induction with 1 mM ribose. Stacks represent the average cell fluorescence in flow cytometry 
from independent biological triplicates. Values in orange are those higher than the average across all mutants 
and wild-type + 2 × SD (considered semi-constitutives), those in magenta are lower than the average −2 × SD 
(considered poorly or non-inducible). Negative stack values in panel A in green denote existing RbsB wild-type 
Ala-positions; those in purple represent the three positions for which no substitutions could be obtained (135T, 
136S and 145F).
www.nature.com/scientificreports/
4Scientific RepoRTS | 7: 8245  | DOI:10.1038/s41598-017-08035-5
Positions of Ala substitution effects. The Ala-substitution mutants with observed effects cover any part 
of RbsB except a few helices (Fig. 3A,B). Not surprisingly, several mutants are located within the ribose binding 
pocket, notably D89A, N190A, D215A and R141A, and to a lesser extent L88A (Fig. 3C). At the cleft entry are two 
mutants T10A and N41A. On the back side of the binding pocket is the flexible hinge region (Fig. 3B) where six of 
the mutants can be found. These are D104A, V106A, I233A, P237A, P262A and D264A (Fig. 3D). Furthermore, 
two mutations causing a semi-constitutive phenotype (S103A and N105A) are also positioned in the hinge region. 
Several more mutants locate in the N-domain of RbsB (Fig. 3B); notably in a peripheral corner in a helix on the 
“top” (K29A, G31A) and within beta-sheets (L6A, L34A, I86A, Fig. 3D–F). Furthermore, prominent arms in the 
C-domain display two groups of consecutive mutants (G144A, which is close to the R141 in the binding site; and 
L195A, G196A and V186A in the arm supporting the N190 binding site residue, Fig. 3D–F). Interestingly, two of 
the positions for which no substitutions could be obtained (T135, S136) locate on the edges of the cleft of RbsB in 
the structure (Fig. 3E), which may therefore be also critical for its folding and functioning.
Several of the critical positions we found here are not absolutely conserved among members of 
the cd06323:PBP1_ribose_binding-domain containing family (Fig.  S3). Interestingly, the third miss-
ing Ala-replacement mutant (F145) is at a conserved position, as is its neighbor G144 (G144A caused 
semi-constitutive expression). Vice-versa, many of the conserved amino acids in this taxonomically extremely 
widespread domain family can be substituted in RbsB by Ala without noticeable effects (Fig. S4, hash-signs).
Mutant nature Position
Amino 
acid
GFPMut2 Fluorescence Fold 
inductionbUninduced Induceda
Wild-type — — 2851 ± 544 23663 ± 2958 8.30
Non-induciblec
6d L 2293 ± 107 1495 ± 34 0.65
10 T 2604 ± 629 1884 ± 454 0.72
215 D 3696 ± 40 2816 ± 25 0.76
89 D 2416 ± 503 1932 ± 295 0.80
29 K 2039 ± 49 1736 ± 38 0.85
41 N 2823 ± 409 2459 ± 84 0.87
190 N 2396 ± 39 2179 ± 92 0.91
186 V 992 ± 133 940 ± 119 0.95
196 G 990 ± 155 950 ± 103 0.96
88 L 1123 ± 55 1103 ± 28 0.98
Poorly induciblee
195 L 1005 ± 37 1594 ± 51 1.59
106 V 1107 ± 262 1761 ± 262 1.59
264 D 3059 ± 161 5726 ± 456 1.87
34 L 2207 ± 229 4432 ± 115 2.01
31 G 2537 ± 343 5761 ± 165 2.27
262 P 1906 ± 418 6004 ± 1649 3.15
104 D 1235 ± 34 4068 ± 596 3.29
141 R 2123 ± 494 7006 ± 1474 3.30
86 I 2246 ± 260 7873 ± 2393 3.51
144 G 2378 ± 89 8926 ± 348 3.75
111 I 1963 ± 170 8728 ± 590 4.45
237 P 2923 ± 244 10267 ± 2976 3.51
233 I 3166 ± 217 10555 ± 2856 3.33
Semi-constitutivesf
105 N 8344 ± 171 35539 ± 219 4.26
103 S 7167 ± 167 33101 ± 1963 4.62
255 E 6824 ± 324 31441 ± 595 4.61
132 I 5741 ± 731 24383 ± 145 4.25
80 Q 5324 ± 203 32831 ± 1549 6.17
63 I 4945 ± 134 20414 ± 660 4.13
154 F 4460 ± 102 23688 ± 340 5.31
240 I 4314 ± 395 23434 ± 3754 5.43
Table 1. Ala-replacement mutants of RbsB causing significant change in ribose induction. aAverage cell 
fluorescence in flow cytometry after 2 h induction with 1 mM ribose, averaged from biological triplicates ± SD. 
bFold-induction is the ratio of the average cell fluorescence with ribose (induced) and without ribose 
(uninduced). cFold-induction at or below 1 in presence of 1 mM ribose. dPositions in bold type-face indicate 
mutants whose expression in the periplasmic space was verified by quantitative peptide mass spectrometry. 
eInduced values lower than the average induction across all mutants including wild-type, minus 2× the SD 
across all mutant induction data. fUninduced values minus their SD higher than the average uninduced value 
across all mutants including wild-type, plus 2× the SD across all mutant uninduced data.
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Discussion
One of the major hurdles in bacterial bioreporter development is the choice of the chemical target receptor pro-
tein. Whereas most current bioreporters have exploited naturally existing transcription regulators or sensory 
proteins with their cognate ligand specificities26, for detection of new (often manmade) molecules it will be nec-
essary to find or engineer new ligand-binding properties27. One of the proposed possibilities for engineering 
new ligand-binding properties has been the periplasmic-binding-protein scaffold, for which crystal structures in 
absence and presence of ligands are known14, 21, 22, 25. Predictions and experimental data from a decade ago sug-
gested that completely new ligand specificities could be obtained on scaffolds such as the ribose-binding protein 
(RbsB) of E. coli, changing, for example, from ribose to trinitrotoluene15. Key results from this work could not 
be reproduced and have been seriously challenged16. It thus appears that our knowledge on the various steps of 
RbsB-ligand signaling, such as binding of the ligand and binding of the ligand-protein complex to the receptor, 
as well as RbsB folding, periplasmic translocation and stability itself, must be as yet incomplete. Hence, attempts 
for prediction of new ligand-binding specificities solely on the basis of modeling of the PBP binding pockets may 
lead to false results.
Here we focused on obtaining a better understanding of the influence of the individual RbsB residues on 
ligand-induced signaling as well as RbsB periplasmic space abundance. A near complete series of Ala-substitution 
mutants of non-Ala residues of RbsB was produced and characterized for loss of ribose-induced signaling in 
E. coli (Table 1). A total of 23 mutants was found, which resulted in stronger decrease than expected by variation 
of GFPmut2 expression from the Trz1-OmpR hybrid signaling pathway upon ribose induction. Several other 
mutations were found that resulted in a significant increase of fluorescence signal irrespective of ribose addition. 
Mutants displaying significant defects in GFPmut2 induction were further examined for RbsB-mutant protein 
abundance in the periplasmic space (Table 2). From the combined results we can infer whether an Ala-substitution 
acts on the signaling pathway itself (hence: ligand and/or receptor binding), on protein abundance (assumed to be 
Strain 
expressing RbsB 
or RbsB mutant
Abundance
Exclusive spectrum countb Normalized on total spectrac Normalized to MglBd
RbsB or RbsBmut MglB RbsB or RbsBmut MglB RbsB or RbsBmut
K29A 9 36 10 38 10e
L34A 20 43 20 44 17
G31A 18 40 20 44 17
N41A 8 45 8 43 7
I63A 13 24 16 29 21
I86A 18 45 17 43 15
D89A 37 32 33 29 43
N105A 61 35 60 34 67
I111A 29 14 37 18 78
I132A 63 34 58 31 71
R141A 43 38 37 33 43
G144A 27 33 27 33 31
N190A 5 53 5 54 4
D215A 62 46 65 48 51
I233A 24 54 24 53 17
P237A 70 33 59 28 80
P262A 51 32 49 31 60
D264A 69 41 73 43 65
RbsB 50 41 57 46 47
RbsB(2) 115 46 134 54 95
L6A 35 0 47 0 NCf
T10A 13 31 10 23 16
L88A 38 47 47 59 31
V106A 65 11 71 12 224
V186A 27 13 18 8 79
L195A 31 24 31 24 49
G196A 36 18 45 22 76
Table 2. Exclusive and normalized mass-spectrometry abundance of periplasmic RbsB or selected alanine-
replacement mutants compared to the internal standard protein MglB. aD-galactose-binding periplasmic 
protein (MglB) was used as internal standard for RbsB quantification based on similar molecular weight and 
abundance. bAbsolute number of detected peptides exclusive to the protein. cNumber of peptides exclusively 
identifying the protein, normalized to the same total number of identified peptides in each sample. dNormalized 
values to the average normalized total spectra values of MglB. eValues in bold indicate periplasmic samples with 
statistically significantly (F-test; p < 0.05) lower abundance than wild-type RbsB as expected from the variance 
of MglB. fNC, no correction because of absence of MglB in periplasm.
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the result of defects in either translation, folding and/or translocation, or stability), or both. Our assumption here 
was that a decrease in periplasmic abundance might lead to a proportionally diminished fluorescence reporter 
output from the signaling chain, although this relation may be more complex for individual RbsB mutants.
First we want to highlight the presumed ribose binding pocket, which has already been subject of a previous 
investigation by Vercillo et al. who constructed 13 alanine-substitution mutants in residues on the basis of their 
proximity to bound ribose in the crystal structure24. In the ribose-binding pocket of RbsB we found five mutants 
leading to a defect in the behavior of the bioreporter (Fig. 3C). Mutants D89A, D215A, R141A, and N190A 
showed a strong loss of inducibility, but the periplasmic abundance of the N190A mutant was proportionally 
as low as the loss in ribose-induced GFPmut2 fluorescence. This suggests that N190 is not so much involved in 
ribose binding but a key residue influencing protein folding, stability and/or translocation into the periplasm. 
Vercillo et al.24 demonstrated that Ala-substutions at positions 89, 215, and 190, cause loss of ribose binding by 
the purified protein. Purified N190A mutant protein displayed a significant decrease in stability24, which is in 
agreement with our findings. R141A was not part of their mutant selection. In contrast, we did not find statisti-
cally significant effects at 1 mM ribose induction of Ala-substitutions on F16, F164, F214 and Q235 as well as N64, 
which were previously reported as losing ribose binding capacity24.
Mutants N13A and F15A, which are located close to the entrance of the cleft, displayed a semi-constitutive 
behavior, similar to I132A and N105A (Table 1 and Dataset 1). Due to their location, N13A and F15A might 
change the ratio between the open and closed conformation of the protein, and, in this way, lead to constant 
recognition by the Trz1 chemoreceptor and thus higher background fluorescence. According to Vercillo et 
al. the purified N13A and F15A mutant proteins (in an L265C RbsB background) are stable and bind ribose, 
albeit (slightly) diminished compared to wild-type24. This may explain their semi-constitutive behavior in our 
reporter background. Mutation of the nearby residue I132, located at the entrance of the pocket, produced an 
even stronger semi-constitutive phenotype as N13A or F15A, which is in agreement with previous results that 
purified I132A has similar stability and ribose-binding as wild-type RbsB24. Position I132 had also been shown by 
Björkman et al. to play a crucial role in the intra-protein connection between the two domains of RbsB (Fig. 3B) 
Effect Position
Induced 
fluorescencea
MS 
expressionb
Normalized 
fluorescencec
Normalized 
abundanced
Wild-type — 23663 47 1 1
Signaling and 
abundance
L6 1495 (23) 0.063 NCe
T10 1884 (8) 0.080 (0.168)
K29 1736 10 0.073 0.212
G31 5761 17 0.243 0.367
L34 4432 17 0.187 0.367
N41 2459 7 0.104 0.150
L88 1103 (15) 0.047 0.323
L195 1594 (24) 0.067 0.512
Abundance
I63 20414 21 0.863 0.445
I86 7873 15 0.333 0.319
N190 2179 4 0.092 0.075
I233 10555 17 0.446 0.365
Signaling
V106 1761 (111) 0.074 2.36
P262 6004 60 0.254 1.276
G196 950 (38) 0.040 0.800
V186 940 (39) 0.040 0.831
D264 5726 65 0.242 1.370
D215 2816 51 0.119 1.093
G144 8926 31 0.377 0.660
R141 7006 43 0.296 0.905
I111 8728 78 0.369 1.659
D89 1932 43 0.082 0.918
P237 10267 80 0.434 1.701
No effect
I132 24383 71 1.030 1.510
N105 35539 67 1.502 1.424
Table 3. Combined deduced effects of selected RbsB Ala-substitution mutants. aAverage GFPmut2 fluorescence 
of cells induced for 2 h with 1 mM ribose (Table 1). Values in italics are less than the average minus 2 × SD. 
bNormalized mass spectrometry abundance (Table 2). Values in bold type-face are those with statistically 
significantly lower abundance than expected from the observed variance. Values in brackets are further 
normalized for ease of comparison to the RbsB wild-type level of 47 (Table 2). cRatio of GFPmut2 fluorescence 
in mutant versus wild-type RbsB. dRatio of normalized RbsB-mut peptide mass count to wild-type RbsB. 99% 
confidence interval: 0.785–1.274. eNC, not corrected because of absence of measurable MglB in the periplasm.
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Figure 3. Positions of the Ala-substitution mutants with the strongest observed effects on ribose induction. 
(A) Crystal structure of closed RbsB with ribose in pyranoside form (PDB: 2DRI), alpha-helices in purple, 
beta-sheets in yellow and turns in cyan. Ribose is placed as licorice-structure. N- and C-domains, nomenclature 
according to ref. 33. (B) Side-view comparison of closed and open conformation RbsB (PDB: 1URP, chain A), 
with “hinge” region and ligand-“cleft” indicated. Residues, whose substitution by Ala caused complete loss of 
induction by ribose in blue; those with lower induction in gold. (C) Detail of the ribose binding pocket in the 
closed form of RbsB. Cyan: residues affecting periplasmic abundance and signaling; magenta, affecting signaling 
only; gold, affecting abundance; green, residues for which no Ala-replacement mutant could be obtained. (D–F) 
Positions of the various mutants and their categorization on the RbsB closed conformation in different rotation 
views. Top part is always the N-domain. Image panels produced using VMD visual molecular dynamics editor32.
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in order to facilitate the closed conformation22. The connection partner for the formation of the van der Waals 
contact is position N4122. An alanine substitution at this place led to a strong growth defect (Fig. S1), a signif-
icant decrease of the periplasmic abundance of the protein and a complete loss of induction (Tables 2 and 3). 
We therefore conclude that this position is both important for protein stability and for ribose- or Trz1 binding 
(Fig. 3F). Notably, also two residues for which no substitution could be obtained, locate in the entry cleft (T135, 
S136, Fig. 3E,F).
On the opposite side of the ligand entrance is the hinge region (Fig. 3B). Here we detected two groups of 
mutation effects, which may therefore influence RbsB’s ability for adopting conformational changes. The first 
group, consisting of D104A, V106A, I233A, P237A, P262A and D264A, led to a significant loss of induction by 
ribose, which became more dramatic the closer the residue’s location to the hinge (Tables 1 and 3, Fig. 3D,E). The 
other group, with S103A and N105A, resulted in opposite, more constitutive behavior, but with maintenance 
of induction by ribose (Table 1). Four of the mutants in this region, D264A, P262A, P237A and N105A, even 
displayed higher periplasmic abundance than wild-type RbsB (Tables 2 and 3), suggesting a decreased cytoplas-
mic pre-folding and thus a potentially higher secretion rate28. Although we did not specifically examine S103A’s 
abundance in the periplasm, we assume it to be similar to N105A because of its high fluorescence value (Table 1). 
The higher background of S103A and N105A mutations, but maintenance of ribose induction potential may be 
due to more limited hinge movement but adoption of a configuration favorable for contact to the receptor. This 
would be in agreement with the measured wild-type stability and similar wild-type binding constant of ribose 
for purified S103A protein24. In contrast, the effect of the mutants D264A, P262A and P237A may be the result 
of an unfavorable change to the hinge region, which prevents adoption of the closed form upon binding of ribose 
or impedes subsequent contacts to the Trz1 receptor (none of these mutations have been previously analyzed).
Mutants L6A, L34A, I86A, and I63A locate within the two β-sheets in the interior of the protein N-domain 
(Fig. 3D,E) and showed a significantly reduced periplasmic abundance, suggesting a strong influence on RbsB 
folding, stability or translocation. The loss of ribose-induced signaling for L6A and L34A was proportionally 
stronger than can be explained from their decreased periplasmic abundance. Therefore, this position may have 
an additional influence on the signaling process. Interestingly, strains expressing L34A also grew poorer (as 
N41A), which may point to these proteins clogging E. coli’s translocation systems28. Surprisingly, mutant I63A 
showed a semi-constitutive response despite a lower periplasmic abundance. Noteworthy, the strain expressing 
mutant L6A showed a complete absence of MglB (galactose-binding protein) in its periplasm, in comparison 
to the other strains (Table 3). This mutant may thus cause extreme folding defects that inhibit translocation of 
other PBPs. The location of many Ala-replacement mutants with lower RbsB periplasmic space abundance in 
the N-domain is in agreement with the location of most spontaneous RbsB suppressor mutants that overcame a 
defect in SecB-dependent translocation19. It suggests that the N-domain (as that part of the protein that passes 
first through the translocation channel) is particularly sensitive to misfolding.
Positions I111, G144 and F145 are situated at two alpha-helices of the C-terminal part (Fig.  3E). 
Ala-substitutions in two of these residues caused a significant loss of induction, which could not (I111A) or 
only partially (G144A) be explained by reduced periplasmic abundance. Mutant F145A could not be obtained, 
despite multiple trials. This is a conserved residue among a wide range of periplasmic-binding proteins of the 
cd06323:PBP1_ribose_binding protein domain family, suggesting it plays a pivotal role (Fig. S3). Similarly, sub-
stitutions in L195, G196, and V186 in other helices and sheets in the C-domain caused drastic effects on induction 
and/or on protein abundance (L195A, Table 3). This suggests some global structural change of the protein result-
ing in a perturbation of the hinge region and thus influencing the relative positions of the residues on the cleft 
side, similar as has previously been suggested on an analysis of the RbsB mutant I111R23.
One would expect to have produced substitutions causing a defect in ribose-bound-RbsB binding to the Trz1 
receptor, leading to decreased signaling and, hence, decreased Gfpmut2 fluorescence. Amidst the list and loca-
tion of mutants causing effects that cannot be more simply explained by mechanistic details of ribose binding 
or hinge-movement, or residues of structural importance (e.g., Gly- or Pro-residues), we find two conspicuous 
mutations: K29A and E255A. Both of these locate to the left outside part of the protein’s N-domain (Fig. 4), but 
whereas substitution in K29A abolishes induction, that in E255A causes a semi-constitutive phenotype (Dataset 1 
and Table 1). Both residues are charged, locate on the outside (Fig. 4) and change their relative orientation 
between open and closed configuration (Fig. 3B). On the other hand, these residues have not been detected in 
previous spontaneous or constructed RbsB mutants with inferred receptor or permease-binding defects19–23. The 
RbsB region contacting Trz1 has not been characterized, but, according to previous work analyzing RbsB mutants 
impaired in ribose chemotaxis, it would cover residues I111 and L107 on the “back” of the protein (Fig. 4) and 
A44, A70, N73 and G134 on the “front” (Fig. 4)23. Part of these residues (A44, A70, N73, I111, L107) overlap 
with the proposed region on RbsB binding the ribose permease20, 22, 23, 29 (Fig. 4). None of the Ala-substitutions 
to those residues (Fig. 4), except I111A, caused measurable loss of Trz1 signaling in our experiments, but D52A 
and R166A showed elevated background expression (Dataset 1), which may be due indirectly to altered ribose 
transport20.
Our study largely expands previous more limited mutation analyses of RbsB20, 23, 24, resulting in a more com-
plete view on the importance of RbsB residues for protein stability and transport, as well as for proper signaling 
in the Trz1 transduction pathway. In addition to the more obvious residues implicated in ribose binding, we 
were able to highlight the importance of various other inconspicuous residues effecting the folding, structure or 
transport of the protein and also the signal transduction towards the chemoreceptor. Several of the positions we 
identified as crucial for proper RbsB functioning had been in fact targeted by the aforementioned RbsB protein 
design study, such as D89(S), R141(S), N190(F) or D215(S)15. Although it is possible that the negative effect of an 
Ala-substitution is absent in another substitution, this suggests that great caution has to be taken when targeting 
residues that are critical for ligand binding (D89, R141, D215) or protein stability and transport (N190). On 
the other hand, it suggests that mutant ligand-binding RbsB with poor structural stability may be improved by 
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further mutating residues implicated in folding or translocation, the importance of which was shown here. We 
expect that our results may help future computational design of RbsB and PBPs more in general, by improving the 
scoring functions used in the force field calculations.
Methods
Strains and growth conditions. All E. coli strains used for this work are listed in Supplementary Table 1. 
For cloning purposes, E. coli strains were cultured at 37 °C on Luria Bertani (LB) medium30, supplemented with 
appropriate antibiotics to select for plasmid maintenance. In case of ampicillin (Amp), a concentration of 100 µg 
ml−1 was used; for chloramphenicol (Cm), we used 30 µg ml−1. Culturing conditions for protein overexpression 
and for reporter assays are specified below.
Library construction. The mutant library was produced by DNA synthesis (DNA2.0, CA, USA) on the 
basis of the sequence provided in Fig. S4. The gene sequence further encoded a C-terminal hexahistidine (His6) 
tag framed by MfeI sites, restriction sites for NdeI (N-terminal), SalI (C-terminal), and for NcoI at the end of the 
signal sequence (Fig. S4). In first instance, the pooled DNA synthesis product was digested with NdeI and SalI 
and ligated into vector pSTV28PAAmcs, cut with the same enzymes (Fig. S5). This reporter construct library was 
cotransformed with pSYK1 into E. coli BW25113ΔrbsB16. The transformants were plated and 800 single colo-
nies were picked, verified by sequencing and organized in a 96-well format. This screening covered 74% of the 
mutants in the library. Further mutants were then recovered individually from the original synthesized templates 
by PCR, which were cloned into pSTV28PAAmcs, cotransformed, verified and stocked as before. A total of 17 
mutants which could not be recovered from the synthesized mutant library were produced individually using 
the DpnI method31. Plasmid pAR3 (with wild-type rbsB in pSTV28PAAmcs; ref. 16) was amplified in the PCR 
using overlapping but reverse complementary primers with point mutations to create Ala-replacements at the 
desired codons in RbsB. The PCR product was then digested by DpnI at 37 °C for 1 h to remove exclusively the 
(methylated) template plasmid DNA. After inactivation of the enzyme at 80 °C for 20 min the PCR product was 
transformed in E. coli DH5a and transformants were selected on LB with Cm. Ten transformants were verified by 
sequencing of the re-amplified rbsB-insert for the presence of the intended mutation in rbsB. If correct, the insert 
was recovered by restriction enzyme digestion and ligated to pSTV28PAAmcs. Those constructs were again veri-
fied by sequencing and if correct, the mutant plasmids were cotransformed into E. coli BW25113ΔrbsB together 
with pSYK1 as before.
Figure 4. Surface exposure of various mutant classes positioned on RbsB in closed conformation with ribose, 
here shown as Van der Waals-atom surface including water molecules (PDB: 2DRI). Secondary structure 
cartoons indicate the positions of protein in FRONT and BACK views. Color code: cyan (K29, G31, N41), 
residues identified here that affect protein abundance and signaling; magenta (V106, P262, D264), residues 
affecting signaling; gold (I233), residue affecting protein abundance only; orange (E255, S103 - just below P262), 
Ala-substitutions causing more constitutive signaling; green (A44, A70, N73, I111, L107), residues affecting 
chemotactic receptor and ribose transport channel binding23; tan (N12, K45, D67), residues affecting ribose 
transport23; iceblue (D52, G134, R166), residues affecting contact to ribose transport channel20. Image panels 
produced using VMD visual molecular dynamics editor32.
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RBP-based bioreporter assays using the Trz1-OmpR hybrid signaling chain. In order to measure 
the capacity of RbsB or its alanine-mutants to induce the Trz1-hybrid-OmpR ompCp-gfpmut2 signaling chain in 
the presence of ribose, we used E. coli BW25113ΔrbsB cotransformed with pSTV-based plasmids (pAR3-K1A – 
pAR3-L272A for the alanine mutants, or pAR3, for wild-type rbsB) and plasmid pSYK1 (to provide the hybrid 
signaling chain)16. Upon induction, these strains produce GFPmut2, the fluorescence intensity of which was 
measured using flow cytometry. The bioreporter assay was optimized for minimal background GFPmut2 expres-
sion and medium fluorescence, according to ref. 16. Strains were inoculated in 96 well plates (F96 Cert.Maxisorp, 
Nunc, Denmark) containing 200 µL of minimal medium with Amp and Cm16 and 20 mM fumarate as sole carbon 
and energy source, with cells from organized stocks stored at −80 °C. Cultures were incubated overnight at 37 °C 
with rotary shaking at 700 rpm. The next morning, a volume of 1 µL of each culture was transferred into 200 µL of 
fresh minimal medium with fumarate in a new 96 well plate16, and incubated for 2 h at 37 °C with rotary shaking 
at 700 rpm. An aliquot of 90 µL of each culture was then removed and mixed with 10 µL of ribose solution (10 mM, 
D-(-)-ribose, Aldrich, USA) in the wells of a new sterile 96-well plate to reach a final ribose concentration of 
1 mM. The remaining cell volume (110 µl) in the wells of the previous (uninduced assay) plate were filled with 
100 µL of PBS to dilute the cell concentration and measured immediately. The ribose containing assay (induced) 
was incubated for another 2 h at 37 °C with rotary shaking and then sampled. Assay plate wells were auto-sampled, 
and values of individual cell forward scatter (FSC) and GFPmut2 fluorescence (FITC-channel) were recorded by 
a Becton Dickinson Fortessa flow cytometer (LRS FortessaTM, Becton Dickinson, USA). The flow rate was set 
to 3 µl s−1 and the cell density was between 100–1000 cells µL−1. Sensitivities for the FSC and the FITC channels 
were set at 350 V and 676 V, respectively. Recorded data were gated to remove background particles. The mean 
fluorescence values of the gated uninduced or induced populations were calculated. All experiments were carried 
out in independent triplicate incubations on the 96-well plate. In all plates, triplicate incubations of E. coli strain 
4175 (carrying wild-type rbsB on pAR3 plus pSYK1) and E. coli strain 4497 (with empty vector pSTV28PAAmcs 
plus pSYK1) served as simultaneous positive and negative controls for ribose induction, respectively. Reported 
fluorescence values are not normalized for plate-to-plate variations.
Periplasmic space RbsB abundance. The abundance of 25 alanine mutants in the E. coli periplasmic 
space was analyzed using direct peptide mass identification, as described previously16. After extraction and sepa-
ration of the periplasmic protein fraction by SDS-PAGE, proteins in a size region of 28–36 kD were excised from 
the gel. Subsequently they were digested with trypsin and peptides were separated on an Ultimate 3000 Nano LC 
System (Dionex), followed by detection in a Thermo Scientific LTQ-Orbitrap XL mass spectrometer (Thermo 
Fisher Scientific, Waltham, MA). Mass spectra were analyzed by Scaffold Viewer (http://www.proteomesoftware.
com/), using protein and peptide identification thresholds of 99.9% and 99.99%, respectively. The minimum 
number of peptides for identification was 1.
Crystal structure mutant positioning. Positions of selected Ala-substitutions were visualized on the 
RbsB ribose-bound (PDB: 2DRI)22 and open conformation crystal structure (PDB: 1URP)21 using the VMD: 
visual molecular dynamics viewer32.
Data availability. All relevant data are uploaded as Reimer_Dataset1.xlsx. Ala-substitution mutants are 
available upon request to the corresponding author.
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